276 related articles for article (PubMed ID: 12936993)
1. Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis.
Betts JC; McLaren A; Lennon MG; Kelly FM; Lukey PT; Blakemore SJ; Duncan K
Antimicrob Agents Chemother; 2003 Sep; 47(9):2903-13. PubMed ID: 12936993
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
Slayden RA; Lee RE; Barry CE
Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
[TBL] [Abstract][Full Text] [Related]
3. The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.
Slayden RA; Barry CE
Tuberculosis (Edinb); 2002; 82(4-5):149-60. PubMed ID: 12464486
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.
Parikh SL; Xiao G; Tonge PJ
Biochemistry; 2000 Jul; 39(26):7645-50. PubMed ID: 10869170
[TBL] [Abstract][Full Text] [Related]
5. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
[TBL] [Abstract][Full Text] [Related]
7. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance.
Banerjee A; Sugantino M; Sacchettini JC; Jacobs WR
Microbiology (Reading); 1998 Oct; 144 ( Pt 10)():2697-2704. PubMed ID: 9802011
[TBL] [Abstract][Full Text] [Related]
8. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.
Kremer L; Douglas JD; Baulard AR; Morehouse C; Guy MR; Alland D; Dover LG; Lakey JH; Jacobs WR; Brennan PJ; Minnikin DE; Besra GS
J Biol Chem; 2000 Jun; 275(22):16857-64. PubMed ID: 10747933
[TBL] [Abstract][Full Text] [Related]
9. Triclosan derivatives: towards potent inhibitors of drug-sensitive and drug-resistant Mycobacterium tuberculosis.
Freundlich JS; Wang F; Vilchèze C; Gulten G; Langley R; Schiehser GA; Jacobus DP; Jacobs WR; Sacchettini JC
ChemMedChem; 2009 Feb; 4(2):241-8. PubMed ID: 19130456
[TBL] [Abstract][Full Text] [Related]
10. Triclosan and its derivatives as antimycobacterial active agents.
Vosátka R; Krátký M; Vinšová J
Eur J Pharm Sci; 2018 Mar; 114():318-331. PubMed ID: 29277667
[TBL] [Abstract][Full Text] [Related]
11. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
Unissa AN; Subbian S; Hanna LE; Selvakumar N
Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA.
Kumar P; Capodagli GC; Awasthi D; Shrestha R; Maharaja K; Sukheja P; Li SG; Inoyama D; Zimmerman M; Ho Liang HP; Sarathy J; Mina M; Rasic G; Russo R; Perryman AL; Richmann T; Gupta A; Singleton E; Verma S; Husain S; Soteropoulos P; Wang Z; Morris R; Porter G; Agnihotri G; Salgame P; Ekins S; Rhee KY; Connell N; Dartois V; Neiditch MB; Freundlich JS; Alland D
mBio; 2018 Dec; 9(6):. PubMed ID: 30563908
[TBL] [Abstract][Full Text] [Related]
13. Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.
Oliveira JS; de Sousa EH; de Souza ON; Moreira IS; Santos DS; Basso LA
Curr Pharm Des; 2006; 12(19):2409-24. PubMed ID: 16842188
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of action of and resistance to rifampicin and isoniazid in Mycobacterium tuberculosis: new information on old friends].
De La Iglesia AI; Morbidoni HR
Rev Argent Microbiol; 2006; 38(2):97-109. PubMed ID: 17037259
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid.
Mdluli K; Slayden RA; Zhu Y; Ramaswamy S; Pan X; Mead D; Crane DD; Musser JM; Barry CE
Science; 1998 Jun; 280(5369):1607-10. PubMed ID: 9616124
[TBL] [Abstract][Full Text] [Related]
16. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
Rozwarski DA; Grant GA; Barton DH; Jacobs WR; Sacchettini JC
Science; 1998 Jan; 279(5347):98-102. PubMed ID: 9417034
[TBL] [Abstract][Full Text] [Related]
17. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
[TBL] [Abstract][Full Text] [Related]
18. Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips.
Fu LM
Tuberculosis (Edinb); 2006 Mar; 86(2):134-43. PubMed ID: 16246625
[TBL] [Abstract][Full Text] [Related]
19. Biological evaluation of potent triclosan-derived inhibitors of the enoyl-acyl carrier protein reductase InhA in drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis.
Stec J; Vilchèze C; Lun S; Perryman AL; Wang X; Freundlich JS; Bishai W; Jacobs WR; Kozikowski AP
ChemMedChem; 2014 Nov; 9(11):2528-37. PubMed ID: 25165007
[TBL] [Abstract][Full Text] [Related]
20. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan.
McMurry LM; McDermott PF; Levy SB
Antimicrob Agents Chemother; 1999 Mar; 43(3):711-3. PubMed ID: 10049298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
